34 Beta E12 (HMWCK) IHC

This test measures the expression and distribution of specific proteins in tissue samples. It aids in diagnosing various conditions by identifying the presence or absence of these proteins, helping doctors understand disease processes, assess tumour characteristics, determine treatment strategies, and monitor response to therapy.

• To diagnose specific diseases or conditions, such as cancer subtypes
• To determine the aggressiveness of a tumour
• To identify the origin of metastatic tumours
• To guide treatment decisions based on the specific markers expressed in the tissue sample

This test may be advised for individuals who:

• Have been diagnosed with cancer or other conditions that require further characterization
• Need to determine the type of cancer or its aggressiveness
• Are undergoing treatment and require monitoring or assessment of response

An abnormal result in IHC Panels with reporting - 34 Beta E12 (HMWCK) may indicate the presence of specific health conditions or markers. However, abnormal results alone are not diagnostic of a particular disease. Your doctor will interpret these results in conjunction with other clinical findings and diagnostic tests to guide further evaluation and treatment.

During this test, a small tissue sample will be collected, typically through a biopsy procedure. The tissue will be processed and stained using specific antibodies to detect protein markers. The stained tissue sections will then be examined under a microscope by expert pathologists, who will analyse the protein expression patterns and provide a detailed report.

• Provide the original histopathology report and relevant clinical and radiological details
• Ensure that you provide paraffin blocks of your tumour sample
• Please reach out to your healthcare provider for specific requirements or instructions.

• Molecular testing: This helps identify specific genetic mutations or alterations associated with certain cancers.
• Cytogenetic testing: It assesses changes in chromosomes that may aid in diagnosing certain conditions.
• Histopathology examination: This evaluates the overall architecture and characteristics of tissue samples.
• Flow Cytometry: This test helps identify and characterise different cells in a sample based on their surface markers.

• IHC Panels with reporting - 34 Beta E12 (HMWCK)
• Immunohistochemistry Panels with reporting - 34 Beta E12 (HMWCK)

Cancer refers to a group of diseases characterised by uncontrolled cell growth. It occurs when normal cells undergo genetic alterations, leading to abnormal cell behaviour. These cells can invade nearby tissues and spread to other parts of the body.